ArticleDiagnostics (Basel, Switzerland)2022

GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors.

John M Ryniawec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.